I have a friend who has stayed alive for several years despite a life-threatening muscle cancer because of a popular chemotherapy drug called Doxil. This summer, despite being CEO of a major biotech firm, he lost access to the drug almost overnight, and he has been scrambling to obtain supplies of it ever since. When I checked around my medical center and other hospitals, I discovered that he wasn’t alone — the problem was rampant, it was nationwide, and it wasn’t restricted to only Doxil, though Doxil was certainly one of the most dramatic examples.
The problem of shortages of many of our life-saving intravenous drugs — including chemotherapy medications, steroids, seizure drugs, blood thinners, antibiotics, and cardiac-emergency treatments — has spiraled out of control.
Keep reading this post . . .
